This report contains market size and forecasts of IVD Infectious Diseases in China, including the following market information:
China IVD Infectious Diseases Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five IVD Infectious Diseases companies in 2020 (%)
The global IVD Infectious Diseases market size is expected to growth from US$ 16620 million in 2020 to US$ 22230 million by 2027; it is expected to grow at a CAGR of 3.8% during 2021-2027.
The China IVD Infectious Diseases market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Researcher has surveyed the IVD Infectious Diseases Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China IVD Infectious Diseases Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China IVD Infectious Diseases Market Segment Percentages,

By Type

, 2020 (%)
Immunochemistry
Molecular Diagnostics

China IVD Infectious Diseases Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China IVD Infectious Diseases Market Segment Percentages,

By Application

, 2020 (%)
Clinical Laboratories
Diagnostic Centers

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IVD Infectious Diseases revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies IVD Infectious Diseases revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories